NASDAQ:GOVX • US3736787058
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GEOVAX LABS INC (GOVX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-19 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2026-01-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-11 | Alliance Global Partners | Initiate | Buy |
| 2024-10-02 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-19 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-19 | Noble Capital Markets | Maintains | Outperform -> Outperform |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 81.5K -78.86% | -100.00% | 3.955M | 2.544M -35.67% | -100.00% | 289.55M | |
| EBITDA YoY % growth | -13.972M 25.31% | -26.669M -90.87% | -25.049M 6.07% | -19.023B -75,843.45% | -22.278B -17.11% | 9.578B 142.99% | |
| EBIT YoY % growth | -14.029M 25.16% | -26.743M -90.63% | -25.144M 5.98% | -23.809M 5.31% | -25.174M -5.73% | 172.55M 785.43% | |
| Operating Margin | -17,213.01% | N/A | -635.82% | -935.90% | N/A | 59.59% | |
| EPS YoY % growth | -13.35 97.04% | -23.95 -79.40% | -5.67 76.33% | -34.04 -500.40% | -27.80 18.35% | 71.02 355.50% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -6.29 -1,996.70% | -8.93 20.67% | -10.20 -16.57% | -11.99 -54.65% | -0.56 91.08% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.999M 40.09% | -5.471M -1.22% | N/A | N/A | N/A |
All data in USD
10 analysts have analysed GOVX and the average price target is 258.19 USD. This implies a price increase of 16138.24% is expected in the next year compared to the current price of 1.59.
GEOVAX LABS INC (GOVX) will report earnings on 2026-03-25, after the market close.
The consensus EPS estimate for the next earnings of GEOVAX LABS INC (GOVX) is -6.29 USD and the consensus revenue estimate is 0 USD.
The consensus rating for GEOVAX LABS INC (GOVX) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.